Puma Biotechnology (PBYI) Interest Expenses (2018 - 2026)

Puma Biotechnology has reported Interest Expenses for 9 years, with the latest figure at $731000.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 66.42% year-over-year to $731000.0; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 54.07% YoY), and the FY2025 full-year result was $6.6 million, down 46.82% from the prior year.
• Interest Expenses for Q1 2026 stood at $731000.0, down from $1.1 million in the prior quarter.
• The five-year high for Interest Expenses was $3.4 million in Q2 2024, with the low at $731000.0 in Q1 2026.
• Historically, Interest Expenses has averaged $2.6 million across 5 years, with a median of $2.9 million in 2022.
• Annual changes were most pronounced in 2023 — Interest Expenses gained 24.32% — and 2026, when it slumped 66.42%.
• Puma Biotechnology's Interest Expenses stood at $3.3 million in 2022, then climbed by 2.29% to $3.4 million in 2023, then declined by 21.85% to $2.6 million in 2024, then plunged by 57.31% to $1.1 million in 2025, then tumbled by 34.67% to $731000.0 in 2026.
• The last three Interest Expenses figures came in at $731000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.